Cephalalgia

Cover image for Cephalalgia

May 1989

Volume 9, Issue Supplement s9

Pages 5–102

  1. Introduction

    1. Top of page
    2. Introduction
    3. Original Article
    4. General Discussion
    5. Concluding Remarks
    1. INTRODUCTION (page 5)

      James W Lance

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00066.x

  2. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. General Discussion
    5. Concluding Remarks
    1. 5-Hydroxytryptamine and its putative aetiological involvement in migraine (pages 10–13)

      James W Lance, Geoffrey A Lambert, Peter J Goadsby and Alessandro S Zagami

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00067.x

    2. Characterization of 5-hydroxytryptamine receptors in the cranial vasculature (pages 19–22)

      Pramod R Saxena, Anton H Bom and Pieter D Verdouw

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00068.x

    3. The pharmacology of the novel 5-HT1-like receptor agonist, GR43175 (pages 23–33)

      Patrick PA Humphrey, Wasyl Feniuk, Marion J Perren, Helen E Connor and Alexander W Oxford

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00069.x

    4. GR43175 does not share the complex pharmacology of the ergots (pages 35–39)

      Wasyl Feniuk, Patrick PA Humphrey and Marion J Perren

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00070.x

    5. The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175 (pages 41–46)

      Marion J Perren, Wasyl Feniuk and Patrick PA Humphrey

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00071.x

    6. The kinetics of 14C-GR43175 in rat and dog (pages 53–56)

      Falkner AA Dallas, Christine M Dixon, Robert J McCulloch and David A Saynor

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00073.x

    7. Early studies with the novel 5-HT1-like agonist GR43175 in healthy volunteers (pages 57–62)

      Patricia A Fowler, Malcolm Thomas, Larry F Lacey, Peter Andrew and Falkner AA Dallas

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00074.x

    8. Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine (pages 63–72)

      VL Perrin, M. Färkkilä, J. Goasguen, A. Doenicke, J. Brand and P. Tfelt-Hansen

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00075.x

    9. Early clinical experience with subcutaneous GR43175 in acute migraine: An overview (pages 73–77)

      P. Tfelt-Hansen, J. Brand, P. Dano, A. Doenicke, LJ Findley, HK Iversen, D. Melchart and HM Sahlender

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00076.x

    10. Initial clinical experience with the use of subcutaneous GR43175 in treating acute migraine (pages 79–82)

      N. Brion, J. Bons, J. Plas, EM Bayliss and C. Advenier

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00077.x

    11. Treatment of acute migraine with subcutaneous GR43175 in West Germany (pages 83–87)

      HA Baar, J. Brand, A. Doenicke, D. Melchart, V. Lüben, M. Tryba and HM Sahlender

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00078.x

    12. Effective improvement of symptoms in patients with acute migraine by GR43175 administered in dispersible tablets (pages 89–92)

      A. Doenicke, D. Melchart and EM Bayliss

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00079.x

    13. Lack of effect of GR43175 on peripheral arteries in man (pages 93–95)

      Thue H Nielsen and Peer Tfelt-Hansen

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00080.x

  3. General Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. General Discussion
    5. Concluding Remarks
    1. General discussion (pages 97–101)

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00081.x

  4. Concluding Remarks

    1. Top of page
    2. Introduction
    3. Original Article
    4. General Discussion
    5. Concluding Remarks
    1. Concluding remarks (page 102)

      James W Lance

      Version of Record online: 25 AUG 2010 | DOI: 10.1111/j.1468-2982.1989.tb00082.x

SEARCH

SEARCH BY CITATION